COSCIENS Biopharma Posts $2.5 Million in Q3 Revenue and $3.45 GAAP Loss Per Share

John Kim

1 min read

Add as a preferred source on Google

COSCIENS Biopharma Posts $2.5 Million in Q3 Revenue and $3.45 GAAP Loss Per Share

Revenue rose 66.7% from a year earlier.

By John Kim

Published Nov 13, 2026, 9:38 PM EST

A glass vial rests on a blank financial statement beside a balance scale / TokenPost.ai

COSCIENS Biopharma Inc. posted third-quarter revenue of $2.5 million, up 66.7% from the same period a year earlier, while recording a GAAP loss of $3.45 per share.

John Kim

John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.